Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Methamphetamine | 2 | 2015 | 166 | 0.400 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2011 | 25 | 0.340 |
Why?
|
| Receptors, Dopamine | 1 | 2011 | 30 | 0.340 |
Why?
|
| Neurogenesis | 1 | 2011 | 63 | 0.330 |
Why?
|
| Corpus Striatum | 1 | 2011 | 121 | 0.320 |
Why?
|
| Central Nervous System Stimulants | 1 | 2011 | 180 | 0.300 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2022 | 568 | 0.220 |
Why?
|
| Histone Deacetylase 2 | 1 | 2015 | 5 | 0.120 |
Why?
|
| Genes, Immediate-Early | 1 | 2015 | 10 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2015 | 21 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2015 | 168 | 0.110 |
Why?
|
| Nucleus Accumbens | 1 | 2015 | 100 | 0.110 |
Why?
|
| Dopamine Antagonists | 2 | 2011 | 48 | 0.100 |
Why?
|
| Raclopride | 1 | 2011 | 8 | 0.090 |
Why?
|
| Androstanes | 1 | 2011 | 7 | 0.090 |
Why?
|
| Drug Administration Routes | 1 | 2011 | 14 | 0.090 |
Why?
|
| Bromodeoxyuridine | 1 | 2011 | 25 | 0.090 |
Why?
|
| Mice, Inbred ICR | 1 | 2011 | 44 | 0.090 |
Why?
|
| Dopamine Agonists | 1 | 2011 | 34 | 0.090 |
Why?
|
| Benzimidazoles | 1 | 2011 | 43 | 0.090 |
Why?
|
| Benzazepines | 1 | 2011 | 33 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1070 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 575 | 0.080 |
Why?
|
| Finches | 1 | 2007 | 23 | 0.070 |
Why?
|
| Sexual Behavior, Animal | 1 | 2007 | 64 | 0.070 |
Why?
|
| Dopamine | 1 | 2007 | 275 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1455 | 0.060 |
Why?
|
| Motor Activity | 1 | 2007 | 437 | 0.050 |
Why?
|
| Anxiety | 2 | 2022 | 874 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 3156 | 0.050 |
Why?
|
| Republic of Korea | 1 | 2022 | 141 | 0.050 |
Why?
|
| Fatigue | 1 | 2022 | 100 | 0.040 |
Why?
|
| Animals | 3 | 2015 | 16992 | 0.040 |
Why?
|
| Mice | 1 | 2011 | 6644 | 0.040 |
Why?
|
| Universities | 1 | 2022 | 559 | 0.040 |
Why?
|
| Male | 3 | 2015 | 23409 | 0.030 |
Why?
|
| Students | 1 | 2022 | 626 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2022 | 661 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 34 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 52 | 0.030 |
Why?
|
| Depression | 1 | 2022 | 863 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 526 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 986 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 1035 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1082 | 0.020 |
Why?
|
| United States | 1 | 2022 | 5205 | 0.020 |
Why?
|
| Young Adult | 1 | 2022 | 5080 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1271 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1857 | 0.020 |
Why?
|
| Flupenthixol | 1 | 2007 | 1 | 0.020 |
Why?
|
| Androstenedione | 1 | 2007 | 19 | 0.020 |
Why?
|
| Drug Implants | 1 | 2007 | 20 | 0.020 |
Why?
|
| Humans | 2 | 2022 | 43102 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 125 | 0.020 |
Why?
|
| Vocalization, Animal | 1 | 2007 | 55 | 0.020 |
Why?
|
| Female | 1 | 2007 | 24698 | 0.000 |
Why?
|